TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) has provided an announcement.
Lepu Biopharma Co., Ltd. announced a change in the composition of its Nomination Committee, with Dr. Pu Zhongjie stepping down and Ms. Pu Jue being appointed as a new member. This change aligns with upcoming amendments to the Listing Rules and Corporate Governance Code, effective July 1, 2025, aimed at enhancing the effectiveness, diversity, and governance practices of the company’s board.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative therapies and products, primarily targeting the healthcare market.
Average Trading Volume: 24,415,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.58B
Find detailed analytics on 2157 stock on TipRanks’ Stock Analysis page.